Tuesday, March 28, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Havana, Feb 26 (Prensa Latina) President Miguel Diaz-Canel on Sunday described the beginning of a clinical trial on the drug NeuralCIM to treat mild or moderate Alzheimer's disease as a new challenge and contribution from Cuba's science.